-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 8, Broad Pharmaceutical issued a voluntary announcement stating that Sirtex Medical Pty ltd, an associate company of the group, the blockbuster anti-tumor drug SIR-Spheres® Yttrium [90Y] resin microspheres have recently been recommended by the National Health Care Professionals Organization (NICE) in the United Kingdom.
NICE is an important organization of the British National Health Service.
In addition, SIR-Spheres® yttrium [90Y] resin microspheres have also recently received FDA approval for clinical trials of primary liver cancer (HCC) to apply for marketing authorization in the United States.